| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |